WeVote
Log In

Bill

Bill

SB 170

Regards investigational treatments for certain illnesses

136th Legislature (2025-2026) Introduced by Steve Huffman and 1 co-sponsor

SB 170 establishes or modifies Ohio's procedures for patients to access investigational treatments for specified medical conditions, balancing experimental therapy access with safety oversight.

Referred to committee
#commerce #healthcare #healthandhumanservices #insurance
0
WeVote Research Nonpartisan
Bill Summary · SB 170

Legislative bill overview

SB 170 appears to establish or modify procedures for accessing investigational treatments for specified illnesses in Ohio. Based on the title alone, the bill likely addresses compassionate use, right-to-try provisions, or expedited access pathways for experimental therapies. The specific illnesses covered and access mechanisms cannot be determined from the available information.

Why is this important

Access to investigational treatments is a critical healthcare policy issue that affects terminally ill patients and their families. These policies balance the potential benefits of experimental therapies against safety oversight and the need for clinical evidence. Ohio's approach could influence how residents access cutting-edge treatments while managing regulatory protections.

Potential points of contention

  • Scope of eligibility: Debate over which illnesses qualify and whether criteria are sufficiently restrictive or too limiting for patient access
  • Safety and oversight: Tension between expanded access and maintaining adequate monitoring for adverse effects and treatment efficacy
  • Liability and accountability: Questions about who bears responsibility if investigational treatments cause harm or fail to help patients

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.